PapersPMID:27038225
Acute p-synephrine ingestion increases fat oxidation rate during exercise.
- findings
- 2
- compound
- 1
- endpoints
- 2
- no difference found
- 1
- Study, every finding
- crossover
- Dose studied, every finding
- 3 mg/kg p-synephrine, single oral dose
What moved
How to read these marks →- Increases maximal fat oxidation rate (MFO)
very limited
“Moreover, p-synephrine increased maximal fat oxidation rate (0.29 ± 0.15 vs. 0.40 ± 0.18 g min(-1) ; P = 0.01) during exercise although it did not affect the intensity at which maximal fat oxidation was achieved (55.8 ± 7.7 vs. 56.7 ± 8.2% VO2peak ; P = 0.51).”
- Population
- 18 healthy subjects, during a cycle ergometer ramp test to volitional fatigue (25 W every 3 min), one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design
What did not
“In comparison with the placebo, the ingestion of p-synephrine did not change energy consumption (1.6 ± 0.3 vs. 1.6 ± 0.3 kcal min(-1) ; P = 0.69) or fat oxidation rate at rest (0.08 ± 0.02 vs. 0.10 ± 0.04 g min(-1) ; P = 0.15).”
- Population
- 18 healthy subjects, at rest, one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design
Study record
- Design
- crossover trial
- Species
- human
- Population
- healthy subjects
- Participants
- 18
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 8
- Declined
- this platform holds no node for the endpoint